Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications

Author(s): L. Wang, G. Huang, B. Sha, S. Wang, Y.L. Han, J. Wu, Y. Li, Y. Du, T.J. Lu, F. Xu

Journal Name: Current Medicinal Chemistry

Volume 21 , Issue 22 , 2014

Become EABM
Become Reviewer
Call for Editor


Heart disease is one of the major global health issues. Despite rapid advances in cardiac tissue engineering, limited successful strategies have been achieved to cure cardiovascular diseases. This situation is mainly due to poor understanding of the mechanism of diverse heart diseases and unavailability of effective in vitro heart tissue models for cardiovascular drug screening. With the development of microengineering technologies, three-dimensional (3D) cardiac microtissue (CMT) models, mimicking 3D architectural microenvironment of native heart tissues, have been developed. The engineered 3D CMT models hold greater potential to be used for assessing effective drugs candidates than traditional twodimensional cardiomyocyte culture models. This review discusses the development of 3D CMT models and highlights their potential applications for high-throughput screening of cardiovascular drug candidates.

Keywords: Bioprinting, cardiac microtissues, cell encapsulation, cell microenvironment, drug screening, high throughput, hydrogels, stem cells, three dimensional, tissue engineering.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 12 December, 2013
Page: [2497 - 2509]
Pages: 13
DOI: 10.2174/0929867321666131212152408
Price: $65

Article Metrics

PDF: 47